[1]
A. Michalski, “Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients”, Curr. Issues Pharm. Med. Sci., vol. 36, no. 4, pp. 221–226, Dec. 2023, doi: 10.2478/cipms-2023-0038.